Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Nuveen Floating Rate Income Fund (JFR) A Good Stock To Buy?

You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors to make a proper and accurate analysis of certain small-cap companies. However, well-known and successful hedge fund investors like Carl Icahn and George Soros hold the necessary resources and abilities to conduct an extensive stock analysis on small-cap stocks, which enable them to make millions of dollars by identifying potential winners within the small-cap galaxy of stocks. This represents the main reason why Insider Monkey takes notice of the hedge fund activity in these overlooked stocks.

Hedge fund interest in Nuveen Floating Rate Income Fund (NYSE:JFR) shares was flat at the end of last quarter. This is usually a negative indicator. At the end of this article, we will also compare Nuveen Floating Rate Income Fund (NYSE:JFR) to other stocks, including Boulder Brands Inc (NASDAQ:BDBD), Enterprise Financial Services Corp (NASDAQ:EFSC), and Cowen Group, Inc. (NASDAQ:COWN) to get a better sense of its popularity.

Follow Nuveen Floating Rate Income Fund (NYSE:JFR)
Trade (NYSE:JFR) Now!

In the eyes of most stock holders, hedge funds are assumed to be slow, old financial vehicles of years past. While there are over an 8000 funds trading today, we choose to focus on the upper echelon of this club, around 700 funds. These investment experts direct the lion’s share of the smart money’s total capital, and by keeping track of their inimitable equity investments, Insider Monkey has formulated a few investment strategies that have historically defeated the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy outstripped the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

Keeping this in mind, let’s take a peek at the fresh action regarding Nuveen Floating Rate Income Fund (NYSE:JFR).

Hedge fund activity in Nuveen Floating Rate Income Fund (NYSE:JFR)

At the end of the third quarter, a total of 4 of the hedge funds tracked by Insider Monkey were bullish on this stock, flat over the last quarter. With the smart money’s capital changing hands, there exists a select group of notable hedge fund managers who were boosting their stakes substantially (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, William Michaelcheck’s Mariner Investment Group has the most valuable position in Nuveen Floating Rate Income Fund (NYSE:JFR), worth close to $6.1 million, comprising 1.2% of its total 13F portfolio. Coming in second is Murray Stahl of Horizon Asset Management, with a $0.6 million position; the fund has less than 0.1% of its 13F portfolio invested in the stock. Remaining professional money managers that are bullish include Mark Coe’s Coe Capital Management, and Tim Mullen’s Swift Run Capital Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.